Pharmaceutical company in the
Canton of Bern
72 companies in Pharmaceutical company based in the Canton of Bern — name and year of registration from the commercial register.
50 of 72 companies
Dr. E. Gräub AG
Since 1947 · 21–50 empl.5.0(10)
Dr. E. Gräub AG develops, manufactures and markets health products for livestock, companion animals and horses. Its range includes its own products as well as selected third-party products.
Dr. Gurtner Pharma AG
Since 1963 · 1–10 empl.4.3(15)
Dr. Gurtner Pharma AG provides machine-based blister packaging of medicines and operates a blister centre that produces pouch blisters in cleanrooms according to GMP guidelines. Services include photo-optical inspection and full documentation, patient-specific packaging and pharmaceutical support of the medication process for patients and care institutions.
GEA Aseptomag AG
Since 2003 · 21–50 empl.5.0(7)
GEA Aseptomag AG refers to GEA’s Aseptomag® valve line, which uses stainless-steel bellows technology to provide hermetic sealing for aseptic and hygienic liquid-processing applications. These valves are used in food, beverage and dairy-related processing.
SPAGYRIK Produktions AG
Since 2002 · 51–100 empl.5.0(5)
The core activity of HEIDAK AG is the manufacture and distribution of natural remedies, in particular spagyric products, which are based on the use of medicinal herbs and other natural substances. Production includes the extraction of spagyric essences through standardized processes and the manufacture of medicines intended to activate the body's self-healing powers.
Phylak Sachsen (Schweiz) GmbH
Since 1997 · 1–10 empl.5.0(3)
Phylak Sachsen (Schweiz) GmbH produces spagyric medicinal products according to Dr. Zimpel's method and provides professional training for physicians, pharmacists and naturopaths. Its portfolio includes plant essences and cosmetic products; manufacturing is subject to GMP quality controls and distribution takes place via pharmacies in several countries.
Galenica AG
Since 2017 · 500+ empl.3.6(38)
Galenica AG is a healthcare company that operates a network of over 20 business units and provides integrated services for pharmacies, pharmaceutical manufacturers, hospitals, nursing homes and other healthcare partners. Its activities include pharmacy retail and wholesale, logistics, pharmaceutical manufacturing, digital health and IT solutions, home-care services and consulting.
InnoMedica Schweiz AG
Since 1988 · 21–50 empl.
The core activity of InnoMedica is the development and production of nanotransport systems for the pharmaceutical industry, particularly for oncology, neurology and immunology. The company focuses on researching and developing nanocarriers that can release active ingredients in a targeted manner in the body, aiming to achieve improved efficacy with reduced side effects. Production takes place in its own GMP-certified nanofactory, which covers the entire value chain from raw material production to final product manufacturing.
Montavit AG
Since 1994 · 1–10 empl.
WALA Schweiz AG
Since 1997 · 21–50 empl.
The core activity of WALA is the development, manufacture and marketing of medicinal products and products based on medicinal plants and anthroposophic medicine.
Phytomed AG
Since 1998 · 11–20 empl.
Phytomed AG offers products for natural health and personal care, including food supplements and aroma and skincare products. It also provides training and continuing education on naturopathic and pharmaceutical topics.
ABJ International Inc.
Since 2000 · 1–10 empl.
ABJ International Inc. operates the Vali-Suisse division, which provides GMP validation and revalidation services for sterilizers, washer-disinfectors, pouch sealers and ultrasonic baths. Its services include testing in accordance with applicable requirements and the preparation of validation reports.
CELLnTEC advanced cell systems AG
Since 2002 · 11–20 empl.
The core activity of CELLnTEC is the development and manufacture of products and technologies for precision cell culture, particularly cell culture media designed for research and clinical applications. The company offers a range of products, including basic and specialized media, primary cells and complementary reagents required for cell culture and the development of cell therapies.
msd GmbH
Since 2003 · 1–10 empl.
msd GmbH is a research-focused biopharmaceutical company that discovers and develops medicines and vaccines. Its main areas include oncology, vaccines, infectious diseases and cardiometabolic disorders, and the company conducts clinical research and trials.
P&G MedChem AG
Since 2003 · 11–20 empl.
P&G MedChem AG trades in chemical raw materials, fragrances, healthcare products, and machinery and accessories for healthcare and cosmetic applications. Its services include sourcing, import and export, logistics, and preparation of shipping and export documents.
Avosano Industrie Service AG
Since 2004 · 101–500 empl.
Avosano Industrie Service AG is a pre-wholesale provider specialising in pharmaceutical logistics for the pharmaceutical industry. It handles the storage, processing and distribution of medicines and provides additional services such as order entry, customer service, quality control and secondary packaging.
Alpen Pharma AG
Since 2006 · 101–500 empl.
Alpen Pharma AG is the Swiss representative of a pharmaceutical group that markets, distributes, manufactures and promotes medicines. The group also provides medicine registration services and plans and conducts clinical trials.
SWAN Isotopen AG
Since 2007 · 21–50 empl.
SWAN Isotopen AG operates a radiopharmaceutical production facility and manufactures GMP-compliant radiopharmaceuticals for molecular diagnostics. In collaboration with research groups at the University of Bern, it develops diagnostic agents and radiotherapeutics, and provides transport services for radioactive materials.
Bavarian Nordic Berna GmbH
Since 2014 · 1–10 empl.
The core activity of Bavarian Nordic is the research, development and production of innovative, life-saving vaccines.
Exopharm AG
Since 2017 · 1–10 empl.
Exopharm AG supplies pharmaceutical products, including branded medicines and generics, and related medical accessories and services to regional distributors. Its services include logistics (including GDP-compliant cold chain), regulatory affairs (pre- and post-marketing and market access) and promotional support.
Space Pharmaceuticals AG
Since 2018 · 1–10 empl.
Space Pharmaceuticals AG provides CRDMO services for peptide research, development and manufacturing, including peptide discovery, custom synthesis and GMP peptide production. The company also offers process and analytical development, preclinical/clinical support and a portfolio of generic peptide APIs.
VETOQUINOL AG
Since 1990 · 51–100 empl.
The company's core activity is the development, manufacture and marketing of products and services for animal health, particularly in the field of veterinary medicine.
Synthena AG
Since 2012 · 1–10 empl.
Synthena AG is a biotechnology company developing medicines based on its tricyclo-DNA technology. Its RNA-modulating drug programs target severe neuromuscular diseases, with the most advanced preclinical program focused on Duchenne muscular dystrophy.
Genpax SA
Since 2020 · 1–10 empl.
Genpax SA develops the IDEM platform for automated analysis of whole-genome sequencing data from bacterial pathogens. The platform supports monitoring transmission events and antimicrobial resistance, and informs infection prevention.
Janssen Vaccines, Zweigniederlassung der Cilag GmbH International
Since 2018 · 51–100 empl.4.0(8)
Janssen Vaccines, Zweigniederlassung der Cilag GmbH International is part of Johnson & Johnson Innovative Medicine and focuses on medicines and therapies in infectious diseases and vaccines. The website highlights research, development, and medical innovation related to vaccines and other therapeutic areas.
GaleniCare AG
Since 2001 · 11–20 empl.3.6(38)
ILIS Institut and Laboratory Dr. Ivan Slacanin
Since 2018 · 1–10 empl.
Cannerald AG
Since 2020 · 21–50 empl.3.3(16)
The core activity of Cannerald is the production of medical cannabis in an indoor vertical farm facility in Switzerland. The company focuses on the manufacture of pharmaceutical-grade cannabis of the highest quality and safety, which is supplied to international customers.
Nonex GmbH
Since 2024 · 1–10 empl.
Nonex GmbH is a biotechnology company researching and developing biodegradable biomaterials and delivery platforms for food applications. Its activities include functional ingredients, sustainable food technologies and systems for the controlled release of nutrients.
Santella AG
Since 2025 · 1–10 empl.
Santella AG develops probiotic live vaccines for poultry health, with a focus on protecting birds against avian pathogenic E. coli. The company works on a sustainable, scalable solution designed to strengthen immunity and reduce the use of antibiotics in poultry farming.
CALDRE AG
Since 2025 · 1–10 empl.
CALDRE AG is a biotechnology company developing RNA therapeutics for cholestatic and fibrotic liver diseases. Its pipeline includes a liver-specific GalNAc-siRNA targeting claudin-3, intended to improve bile flow and prevent fibrosis.
BLEEDnFIRE Therapeutics AG
Since 2025 · 1–10 empl.
BLEEDnFIRE Therapeutics AG is a biotechnology company developing RNA-based therapies for bleeding disorders. Its lead program, BnF-001, is a siRNA platform designed to modulate Protein S and restore hemostatic balance.
Gumms Nutrition GmbH
Since 2025 · 1–10 empl.
Gumms Nutrition GmbH offers creatine gummies as a dietary supplement. The company sells a vegan, sugar-free gummy product with creatine monohydrate and handles shipping within Switzerland.
imunaris GmbH
Since 2025 · 1–10 empl.
imunaris GmbH provides commercial and medical services to pharmaceutical companies entering and operating in markets, with a focus on vaccines. Its work includes market access, medical affairs, product launches and distribution, as well as AI consulting and development of an electronic quality management system for pharmaceutical wholesalers.
vitronco AG
Since 2026 · 1–10 empl.
vitronco AG conducts preclinical oncology research and develops human-derived, target-specific 3D in vitro tumor models. The models support research on antibody-based cancer therapies, including antibody-drug conjugates, and assessment of drug efficacy, mechanisms of action and toxicity.
NANOVETORES TECNOLOGIA S/A, Florianopolis (BR), Bern branch
Since 2026 · 1–10 empl.
NANOVETORES TECNOLOGIA S/A, Florianopolis (BR), Bern branch develops nanoencapsulated active ingredients and products for cosmetic formulations. The company offers solutions for skincare, haircare, bodycare and functional makeup, together with technical documentation and project support.
HGE-CH GmbH
Since 2020 · 1–10 empl.
HGE-CH GmbH markets Olaris full-spectrum hemp extracts offered as tinctures in MCT carrier oil. The products are presented as cosmetics for skin care, manufactured in Switzerland, and accompanied by external laboratory analysis certificates available per product.
Sonasenz GmbH
Since 2024 · 1–10 empl.
Sonasenz GmbH distributes liquid food supplements and natural products under the Chlorella Dr. Ray brand. The range includes Chlorella, herbal and plant-complex formulations processed using methods such as micronisation, fermentation and tincturing.
NaturMed GmbH
Since 2025 · 1–10 empl.
NaturMed GmbH provides treatments based on the principles of Traditional Chinese Medicine. Its services include acupuncture, Tuina massage, auriculotherapy, moxibustion, cupping and individual nutritional advice.
Asklep Pharma Consulting GmbH
Since 2025 · 1–10 empl.
Asklep Pharma Consulting GmbH provides operational support in GDP quality management, as a Swiss responsible person (FvP), and in regulatory affairs. Its services include preparing and improving SOPs, managing deviations and changes, and maintaining regulatory dossiers and post-approval activities.
Learma-Empire Sàrl
1–10 empl.
Learma-Empire Sàrl sells dietary supplements for beauty and wellbeing, including a marine collagen product with vitamin C, hyaluronic acid and vitamin B3. Its range also includes accessories and product bundles.
mitotronic GmbH
Since 2007 · 1–10 empl.
Ledermann S.A.
Since 1953 · 1–10 empl.
Dimedical AG
Since 1966 · 1–10 empl.
Beatrice Borer-Stiftung zur Erforschung humaner monoklonaler Antikörper
Since 1984 · 1–10 empl.
Bioprod AG
Since 1992 · 1–10 empl.
Laboratoire Central, F. Jolissaint
Since 1993 · 1–10 empl.
PharmaDoc GmbH
Since 2005 · 1–10 empl.
Posimed Radiopharm AG
Since 2005 · 1–10 empl.
PharmaCo GmbH
Since 2008 · 1–10 empl.
2G medical GmbH
Since 2011 · 1–10 empl.
Pharmaceutical company in the Canton of Bern
Pharmaceutical company in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 6, 2026
Largest places
Bern35Pharmaceutical company in other places
By canton